Tight glycemic control is the only strategy convincingly shown to prevent or delay the development of DPN and CAN in patients with type 1 diabetes A and to slow the progression of neuropathy in some patients with type 2 diabetes. B
Tight glycemic control is the onlystrategy convincingly shown toprevent or delay the developmentof DPN and CAN in patients withtype 1 diabetes A and to slow theprogression of neuropathy in somepatients with type 2 diabetes. B